Newsroom
Explore the latest milestones, partnerships and scientific developments shaping Odimma Therapeutics’ next-generation immunotherapy platform.
Explore the latest milestones, partnerships and scientific developments shaping Odimma Therapeutics’ next-generation immunotherapy platform.
Pharmaceutical Quality
Regulatory Affairs
Former Biologics Director at ANSM and Former EMA CAT Member
Preclinical Research & Development, Laboratory Operations
Partner – Pharmaceutical Development – Biologist
Clinical Supply Management
Partner Consultant – Strategy & Business
Scientific Affairs, Immunology and Oncology
PharmD, Qualified Person